Stocks and Investing Stocks and Investing
Wed, March 25, 2020
Tue, March 24, 2020

Swayampakula Ramakanth Maintained (CASI) at Strong Buy with Decreased Target to $35 on, Mar 24th, 2020


Published on 2024-10-27 00:51:12 - WOPRAI, Swayampakula Ramakanth
  Print publication without navigation


Swayampakula Ramakanth of HC Wainwright & Co., Maintained "CASI Pharmaceuticals, Inc." (CASI) at Strong Buy with Decreased Target from $70 to $35 on, Mar 24th, 2020.

Swayampakula, nor any peers, have made any analyst calls on CASI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources